$3.540
-0.310 (-8.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
APUS Prediction & Forecast by Similar Chart Analysis
Alphio's APUS stock price prediction model matches the current Apimeds Pharmaceuticals US Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.52 (-0.58%). The 1-week path is $3.52 (-0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Apimeds Pharmaceuticals US Inc Stock?
Given the current price of 3.87, the RSI of 30.157 indicates that the stock is oversold, but the significant year-to-date change of -97.68% and negative net income figures suggest that the company is struggling financially. The recent leadership changes and settlement agreements may provide some hope for recovery, but the risks are substantial, particularly with a projected trajectory indicating a potential future change of +243.47% based on historical patterns, which is speculative at best. The main risk is the company's current liabilities exceeding its assets, leading to a current ratio of 0.00.
APUS stock price ended at $3.54 on Tuesday, after losing -8.76%
Apimeds Pharmaceuticals US Inc (APUS) last closed at $3.54, losing -8.76%. These facts feed the 1-day and 1-week APUS price prediction above.
Forecast Drivers
Apimeds Pharmaceuticals US Inc (APUS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches APUS, ranked by similarity.
Seasonality analysis for APUS
Historically the probability of a positive September return for APUS is 0.00%. January offers the highest probability of a positive month at 75.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for APUS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $1.30 | $1.58 | $1.73 | -55.38% |
| Oct 2026 | $1.58 | $1.66 | $2.13 | -53.13% |
| Nov 2026 | $1.80 | $2.14 | $2.61 | -39.63% |
| Dec 2026 | $1.92 | $1.96 | $2.05 | -44.59% |
In 2026, Apimeds Pharmaceuticals US Inc (APUS) is projected to range from $1.30 to $2.61.
Apimeds Pharmaceuticals US Inc 2026 monthly forecast
In Sep 2026, Apimeds Pharmaceuticals US Inc is projected to average $1.58, with a low of $1.30 and high of $1.73.
In Oct 2026, Apimeds Pharmaceuticals US Inc is projected to average $1.66, with a low of $1.58 and high of $2.13.
In Nov 2026, Apimeds Pharmaceuticals US Inc is projected to average $2.14, with a low of $1.80 and high of $2.61.
In Dec 2026, Apimeds Pharmaceuticals US Inc is projected to average $1.96, with a low of $1.92 and high of $2.05.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.